Denmark: A recent study published in the Journal of the American Medical Association (JAMA) has shed light on the varying ...

Meanwhile, the review proposes an algorithm for the prevention and treatment of LVT based on ... Given their established efficacy in treating atrial fibrillation (AF) and venous thromboembolism, it is ...

TAT and several other markers demonstrated an ability to predict the development of venous thromboembolism in patients with cervical cancer.

Novartis has announced its acquisition of Anthos Therapeutics, a Boston-based biopharmaceutical company focused on developing abelacimab, an inve ...

This has the potential to translate into clinical risk, due to poor resourcing and planning of VTE prevention, diagnosis and treatment. Overall, a VTE incidence of ~100 per 100 000 person-years is ...

Cancer Prevention Research publishes articles that focus on cancer prevention, preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis ...

Rivaroxaban is currently being evaluated for the prevention of VTE in medical patients, for the treatment of acute VTE, for the prevention of stroke in patients with atrial fibrillation ...

Incidence of venous thromboembolism is across all severities of COVID-19 ... for cardiovascular investigations of patients exposed to COVID-19 are important in prevention and timely treatment of ...

The goal of the TIGHT K trial was to evaluate if prescribing relaxed control of potassium levels and only giving supplements in the rare event that levels became pathologically low was equally as ...

Overall compliance with indicators for VTE was 51%, and ranged from 34% to 64% for aggregated sets of indicators. Conclusions The prevention and management of VTE was appropriate for only half of the ...